In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma.
- DOI
- 10.1016/j.clml.2026.08.002
- Published
- 2026-08-07
- Container
- Clin Lymphoma Myeloma Leuk
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2026.08.002,
title = {In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma.},
author = {Maulhardt M and Kolloch LJ and Westhofen G and Aydilek E and Laage ME and Plate C and Büntzel J and Angleitner AC and Thomson K and Jung W and Hasenkamp J and Shumilov E and Wulf GG.},
year = {2026},
journal = {Clin Lymphoma Myeloma Leuk},
doi = {10.1016/j.clml.2026.08.002},
url = {https://doi.org/10.1016/j.clml.2026.08.002}
}RIS
TY - JOUR TI - In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma. AU - Maulhardt M AU - Kolloch LJ AU - Westhofen G AU - Aydilek E AU - Laage ME AU - Plate C AU - Büntzel J AU - Angleitner AC AU - Thomson K AU - Jung W AU - Hasenkamp J AU - Shumilov E AU - Wulf GG. PY - 2026 JO - Clin Lymphoma Myeloma Leuk DO - 10.1016/j.clml.2026.08.002 UR - https://doi.org/10.1016/j.clml.2026.08.002 ER -
APA
M, M., LJ, K., G, W., E, A., ME, L., C, P., J, B., AC, A., K, T., W, J., J, H., E, S., & GG., W. (2026). In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma.. Clin Lymphoma Myeloma Leuk. https://doi.org/10.1016/j.clml.2026.08.002
Source records
- europe-pmc · retrieved 2026-09-25T14:34:58.923Z